BW...just be careful as the CEO's time frame may be shorter than yours...
In Jan. of this year he became Exec. Vice Chairman of Coronado Biosciences (CNDO) and was awarded 4MM shares (6MM total), vesting periodically through 2019. I'm not sure how a CEO in New York manages to simultaneously be Exec. Vice Chairman for another company in Maine, but likely one of these is only temporary. Of course this could be a good thing if the trial data is strong and a buyout follows. Its unlikely a 14-person company in Columbus Circle (no lab space) will develop or commercialize either compound.